Drug Database
TR

travoprost (Travatan Z / Travantan Z / Travatanz)

✓ Approved

Novartis AG · PTGFR · Small Molecule

What is travoprost?

travoprost is a small molecule developed by Novartis AG. It is approved for therapeutic indications via others.

Drug Profile

Brand NamesTravatan Z, Travantan Z, Travatanz
CompanyNovartis AG
Drug ClassSmall Molecule
Molecular TargetPTGFR
RouteOthers
StatusApproved
Sources: ClinicalTrials.gov, Novartis AG

Mechanism of Action

Molecular Targets

travoprost acts on 1 molecular target:

PTGFRprostaglandin F receptor (FP)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

travoprost is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Eye disordersGlaucoma✓ Approved

Related Research Articles

Unable to load articles right now.

Ask about travoprost